Public Company News
Penetrium™ Breaks Oncology Barriers: The Solution to Cold Tumors and Metastatic Cancer Unveiled at AACR 2025
* Penetrium™ Achieves Historic Breakthrough * Overcoming Cold Tumor Failure and the Challenge of Metastatic Cancer in Immunotherapy and Antibody Therapy * Presented at AACR 2025, Chicago CHICAGO, May 7, 2025 /PRNewswire/ -- Hyundai Bioscience presented the results of its Penetrium™ combinati...
HANYUL Exclusively Launches at Sephora, Bringing Authentic Korean Beauty to U.S. Consumers
NEW YORK, May 7, 2025 /PRNewswire/ -- HANYUL, a renowned leader in Korean beauty, is set to launch at Sephora onMay 16, 2025. This exciting new partnership will bring HANYUL's signature skincare to U.S. consumers both online and in Sephora stores nationwide. Known for combining the finest tradit...
Lunit to Power Germany's Largest Private Radiology Network with AI Imaging
The five-year framework agreement covers phased rollout of Lunit's AI suite—including chest X-ray, mammography, tomosynthesis, and fracture detection—across 79 Starvision sites SEOUL, South Korea, May 7, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics ...
Nature's Miracle Holding Inc. Announces Up to $20 Million Financing with GHS Investment
ONTARIO, Calif., May 7, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology, today announced that the Company has entered into an equity purchase financing agreement (the "Financing") with GHS Investments L...
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids
* Primary Endpoint Met: Statistically significant reduction in heavy menstrual bleeding achieved in all dosage of Merigolix groups compared to placebo * Broader Therapeutic Potential: Positive Phase 2 results in both uterine fibroids and endometriosis could place Merigolix as a strong best-in...
Zepp Health Corporation to Report First Quarter 2025 Financial Results on May 19, 2025
Earnings Call Scheduled for 9:00 p.m. ET on May 19, 2025 MILPITAS, Calif., May 7, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it will report its first quarter 2025 unaud...
Baozun to Announce First Quarter 2025 Unaudited Financial Results on May 21, 2025
SHANGHAI, May 7, 2025 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital commerce enabler inChina, today announced that it will release its unaudited financial results for the first quarter e...
CreateAI Releases White Paper on how AI Transforms Animation Production
BEIJING, May 6, 2025 /PRNewswire/ -- CreateAI Holdings Inc. (OTCMKTS: TSPH) ("CreateAI" or the "Company"), a global artificial intelligence technology company, today announced the release of its "White Paper on the Application and Development of Multimodal Generative Technology in Animation Produ...
CStone Presents Preclinical Results of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC) at 2025 AACR
SUZHOU, China, May 6, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that poster presentations of preclinical data of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bis...
Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Post-Ocular Surgery Inflammation and Pain for Mexico
TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals (" Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights inMexico for the commercialization of clobetasol propionate ophthalmic...
Golden Heaven Group Holdings Ltd. Announces 25 for 1 Share Consolidation
NANPING, China, May 6, 2025 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (" Golden Heaven" or the "Company") (Nasdaq: GDHG), an amusement park operator in China, today announced that the Company's board of directors approved on April 23, 2025 that the authorized, issued, and outstanding shares...
XChange TEC.INC Announces Plan to Implement ADS Ratio Change
SHANGHAI, May 6, 2025 /PRNewswire/ -- XChange TEC.INC (NASDAQ: XHG) (the "Company") today announced that it plans to change the ratio of the American depositary shares ("ADSs") representing its Class A ordinary shares from one (1) ADS representing one hundred and twenty (120) Class A ordinary sha...
Xiao-I Corporation Expands Strategic Partnership with AIA China Through RMB 3-4 Million AI Solutions Deal
SHANGHAI, May 6, 2025 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI), a leading AI enterprise, announced the expansion of its partnership with AIA China, a leading insurance provider, through a one-year contract valued at RMB 3–4 million. This collaboration underscores Xiao-I's position as a p...
Webull Announces Collaboration with Visa
With Webull and Visa Direct, users can move money to and from investment
accounts in real-time[1]
NEW YORK, May 6, 2025 /PRNewswire/ -- Webull
Formosa Pharmaceuticals and Almac Discovery Announce Licensing Agreement for ALM-401, a First-in-Class Bispecific ADC targeting EGFR/ROR1 for the Treatment of Solid Tumors
TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Almac Discovery, aNorthern Ireland-based research driven drug discovery company, for exclusive rights to the commercializ...
SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats
* Company aims to develop a bird flu vaccine with rapid mass production and variant responsiveness. * SK bioscience and KDCA join forces to build a national pandemic preparedness and response system for potential next-pandemic avian influenza. * "We will promote global public health and grow...
FIC Global Expands Optical Transceiver Business to Enable Innovation at the Speed of Light
TAIPEI, May 6, 2025 /PRNewswire/ -- FIC Global Inc.
Canadian Solar Launches Cutting-Edge SolBank 3.0 Plus at Intersolar Europe
KITCHENER, ON, May 6, 2025 /PRNewswire/ -- Canadian Solar Inc
Canadian Solar Releases New TOPCon 2.0 / 660 Wp N-Type Module with up to 24.4% Efficiency for Utility and C&I PV Systems
KITCHENER, ON, May 6, 2025 /PRNewswire/ -- Canadian Solar Inc.
ZKH Group Limited to Announce First Quarter 2025 Financial Results on Tuesday, May 20, 2025
SHANGHAI, May 6, 2025 /PRNewswire/ -- ZKH Group Limited ("ZKH" or the "Company") (NYSE: ZKH), a leading maintenance, repair and operations ("MRO") procurement service platform inChina, today announced that it will release its unaudited financial results for the first quarter of 2025, onTuesday, M...
Week's Top Stories
Most Reposted
Asia Pacific Travellers Seek Familiarity, Practicality, Flexibility Amid Shifting Global Dynamics: Visa Report
[Picked up by 326 media titles]
2026-06-16 10:00Visa and Mintoak Join Forces to Bring Merchant SaaS Capabilities to Acquirers Across Asia Pacific
[Picked up by 313 media titles]
2026-06-17 11:00Affinidi and CardInfoLink Put the Missing Trust Layer for AI Agents into Production
[Picked up by 301 media titles]
2026-06-19 09:00NOVVA Group acquires 120 MWp Philippines solar project, anchoring its AI-era power platform in Southeast Asia
[Picked up by 300 media titles]
2026-06-19 11:12MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform
[Picked up by 300 media titles]
2026-06-18 22:01